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Abstract
Background: We have recently shown that expression of the cell adhesion molecule E-cadherin is required for LIF-
dependent pluripotency of mouse embryonic stem (ES) cells.
Methodology: In this study, we have assessed global transcript expression in E-cadherin null (Ecad-/-) ES cells cultured in
either the presence or absence of LIF and compared these to the parental cell line wtD3.
Results: We show that LIF has little effect on the transcript profile of Ecad-/- ES cells, with statistically significant transcript
alterations observed only for Sp8 and Stat3. Comparison of Ecad-/- and wtD3 ES cells cultured in LIF demonstrated
significant alterations in the transcript profile, with effects not only confined to cell adhesion and motility but also affecting,
for example, primary metabolic processes, catabolism and genes associated with apoptosis. Ecad-/- ES cells share similar,
although not identical, gene expression profiles to epiblast-derived pluripotent stem cells, suggesting that E-cadherin
expression may inhibit inner cell mass to epiblast transition. We further show that Ecad-/- ES cells maintain a functional b-
catenin pool that is able to induce b-catenin/TCF-mediated transactivation but, contrary to previous findings, do not display
endogenous b-catenin/TCF-mediated transactivation. We conclude that loss of E-cadherin in mouse ES cells leads to
significant transcript alterations independently of b-catenin/TCF transactivation.
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Introduction
E-cadherin is a member of the classical cadherin family and is
expressed on most epithelial cells, including ES cells [1,2]. The
extracellular domain of E-cadherin interacts in a homophilic
calcium-dependent manner with E-cadherin molecules on neigh-
bouring cells, thereby facilitating cell-cell contact [1,3]. E-cadherin
is essential for embryogenesis since E-cadherin null embryos fail to
develop beyond the blastocyst stage [2], reflecting loss of epithelial
integrity in both the trophectoderm and inner cell mass [2,4]. Loss
of cell surface E-cadherin is a defining characteristic of epithelial-
mesenchymal transition (EMT), which is required for ingression of
epiblast cells within the primitive streak during early embryonic
development [1,5] and is associated with tumour cell metastasis
[6,7]. The cytoplasmic region of E-cadherin binds to b-catenin,
allowing interaction with the actin cytoskeleton via the interme-
diate protein a-catenin and, most likely, Epithelial Protein Lost In
Neoplasm (EPLIN) [8]. In addition, p120-catenin binds to the
juxta-membrane region of the E-cadherin cytoplasmic domain
and contributes to stabilisation of the cadherin-catenin complex by
preventing clathrin-mediated endocytosis [9]. Besides its structural
role at the cell membrane, b-catenin can also function as a
transcriptional regulator in response to Wnt signals [10]. Under
normal conditions, b-catenin protein turnover is regulated by a
specific complex formed by Glycogen Synthase Kinase 3b
(GSK3b), APC protein and Axin, leading to proteosomal
degradation. Upon Wnt activation, triggered by numerous Wnt
proteins interacting with Frizzled receptors, b-catenin degradation
is inhibited and the protein is translocated into the nucleus where
it interacts with the T-Cell Transcription Factor/Lymphoid
Enhancer-binding Factor (TCF/LEF) complex and regulates
expression of Wnt target genes.
During development E-cadherin is regulated spatio-temporally,
allowing cellular migration and morphogenesis [1]. Abnormal
canonical Wnt activity has been associated with malignant
progression of epithelial cancers, in particular gastric tumours,
and, in some cases, this transformation has been associated with
loss of cell-cell contact via down-regulation of E-cadherin [11].
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catenin protein and negatively interfere with its transcriptional
function whilst E-cadherin down-regulation in epithelial cells has
been implicated in higher b-catenin-mediated transactivation [12].
Canonical Wnt signalling has also been associated with mainte-
nance of pluripotency in both mouse and human ES cells [13,14].
Sato et al. [13] showed that culture of mouse ES cells with the
GSK3 inhibitor BIO resulted in maintenance of pluripotency in
these cells in the absence of Leukaemia Inhibitory Factor (LIF). In
addition, Miyabayashi and colleagues have described a method for
preventing spontaneous differentiation of ES cells using the small
molecule IQ-1, which increases b-catenin/CBP-mediated tran-
scriptional activation [15]. Recently, mouse ES cells have been
derived from blastocysts using a chemically defined medium
containing Fibroblast Growth Factor 2 (FGF2), Activin A and BIO
[16]. However, b-catenin-mediated signalling is not necessary for
the maintenance of ES cell pluripotency factors Nanog, Sox2 and
Oct3/4 as b-catenin-/- mouse ES cells have been isolated and
cultured successfully in vitro exhibiting dependency on the Activin/
Nodal and FGF cascades rather than LIF/BMP (Bone Morpho-
genic Factor) [17]. Therefore, whilst b-catenin appears dispensable
for the maintenance of pluripotency and self-renewal of ES cells, it
is still unclear whether b-catenin-mediated transactivation plays a
functional role in E-cadherin-/- ES cells.
As well as acting as an inhibitor of signalling by sequestering
catenins, E-cadherin also plays a role in repressing ligand
activation of receptor tyrosine kinases (RTKs) such as EGFR,
Neu/ErbB2, insulin-like growth factor receptor IGF1R and c-Met
[3,18]. Interestingly, some of these kinases have been associated
with induction of EMT in epithelial cells following activation of E-
box binding repressors of E-cadherin, such as Snail [19]. A further
binding partner of E-cadherin is PIPKIc, which may play a role in
maintaining integrity of the cadherin/catenin complex since
ablation of PIPKIc in human epithelial cells results in loss of
plasma membrane localisation of E-cadherin [3]. Moreover,
tyrosine phosphorylation of PI(3)K by c-Src leads to the
recruitment and interaction of the former with the E-cadherin/
b-catenin complex resulting in activation of Akt [20,21].
Recruitment of PI3K by the E-cadherin/catenins complex is also
fundamental for the calcium-induced differentiation of human
keratinocytes [22]. Therefore, E-cadherin plays a significant role
in both positively- and negatively- regulating exogenous signals to
maintain epithelial cell integrity.
We have previously demonstrated that differentiation of ES cells
is associated with an EMT-like event, including an E-cadherin to
N-cadherin switch at the cell surface and the upregulation of
various metalloproteinases (MMPs) [6,7]. In addition, we have
recently shown that abrogation of E-cadherin in mouse ES cells
results in modification of the cell response to exogenous factors
[17]. For example, E-cadherin-depleted cells exhibit LIF-inde-
pendent self-renewal and differentiation was induced upon
Activin/Nodal signalling pathway inhibition. In this study, we
further elucidate the role of LIF in Ecad-/- ES cells by comparing
the gene transcription profiles of the cells grown in the presence
and absence of LIF. We have also investigated the impact of E-
cadherin depletion in ES cells by analysing global gene transcript
expression in wtD3 and Ecad-/- ES cells cultured under standard
LIF-conditions. In addition, we have investigated b-catenin/TCF
transactivation in Ecad-/- ES cells to determine whether this
complex is intrinsically active within these cells. In summary, we
show that absence of E-cadherin in ES cells results in significant
alterations in transcript expression in a wide range of cellular
processes compared to wtES cells. In addition, we demonstrate
that LIF exerts a limited effect on the transcriptional profile of




Mouse D3 (129/Sv+c/+p), E-cadherin-/- (derived from D3 ES
cells; a kind gift from Professor Rolf Kemler, Germany) and
MESC20 (129/OLA) ES cells were cultured on gelatinised plates
in knockout D-MEM medium containing 10% (v/v) Foetal Calf
Serum (FCS), 2mM L-glutamine, 1% (v/v) non-essential amino
acids and 0.1% (v/v) 2-mercaptoethanol (all Invitrogen, Paisley,
UK) and 1000U/ml LIF (ESGRO, Millipore, Watford, UK) as
previously described [17]. Ecad-/- ES cells were also cultured for
12 days in the absence of LIF under a normal passaging regimen
prior to experimental analysis. All ES cells presented in this study
exhibited normal karyotypes.
Wnt activation reporter system
To analyse the level of canonical Wnt activation in wtD3 and
Ecad-/- ES cells, 2 mg of the Wnt reporter plasmid TOPflash or
the relative negative control FOPflash (Millipore, Watford, UK)
were transfected into ES cells using the mouse ES cell
NucleofectorH system (Amaxa Biosystems, Wokingham, UK) as
previously described [17]. 0.5 mgo faRenilla plasmid (Promega,
Southampton, UK) was transfected together with the reporter
plasmids and used for normalisation in the Dual-Luciferase
Reporter assay. After transfection, cells were cultured in standard
medium or with addition of the GSK3 inhibitor BIO at a final
concentration of 2 mM and 5 mM for wtD3 ES cells and 1 mM and
2 mM for Ecad-/- ES cells (or equivalent volume of DMSO as
control). A Dual-Luciferase Reporter assay (Promega, South-
ampton, UK) was performed 24h after transfection according to
the manufacturer’s instructions. The assay was performed on the
automatic Berthold Detection System and the Luciferase/Renilla
luminescence ratio was calculated for each well. Results show
mean 6 SD of one single experiment; at least three independent
experiments were performed.
Quantitative assay for b-catenin protein
1610
5 cells/well were seeded into a gelatinised 96-well plate
and cultured for 24h as described above and fixed overnight at
4uC with 4% (w/v) paraformaldehyde (PFA, Sigma, Dorset, UK)
in PBS. Imagen Biotech (Manchester, UK) performed a b-catenin
immunofluorescence quantification assay according to the follow-
ing optimised protocol. Cells were stained with the primary anti-b-
catenin antibody (1:100, Abcam ab6302, Cambridge, UK), diluted
in 500 mg/ml digitonin/PBS at room temperature for 1h.
Secondary antibody goat anti-rabbit Alexa488-conjugated diluted
1:500 in PBS with addition of 25 mg/ml Hoescht solution
(Invitrogen, Paisley, UK) was incubated for 30min at room
temperature. After further fixation in 1% formaldehyde for 15min,
cells were kept in PBS and visualised using a Cellomics Arrayscan.
A specific Arrayscan algorithm was used to quantify b-catenin in
the various cellular compartments (nucleus, cytoplasm and cell
membrane). To distinguish between transcriptionally active and
inactive b-catenin protein pools, the protein in the cytoplasmic
and the membrane compartments are presented together
(cytoplasm+membrane).
Microarray analysis
wtD3 and Ecad-/- ES cells were grown in standard medium
+LIF and Ecad-/- ES cells were also cultured in the absence of
LIF for 12 days under a normal passaging regimen. RNA was
Global Transcript Alterations in Ecad-/- ES Cells
PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e21463extracted as previously described [17] and microarray analysis
performed by the Microarray Facility of Life Sciences (The
University of Manchester, UK) using Affymetrix genome Mouse
430 v.2 chips. Technical quality control was performed with
dChip (V2005) (www.dchip.org) using default settings. Background
correction, quantile normalization, and gene expression analysis
were performed using GCRMA in Bioconductor [23]. A
dendrogram of array relationships was performed by hierarchical
clustering (Euclidean distance) with Partek Genomics Solution
(version 6.5, Copyright 2005, Partek Inc., St. Charles, MO, USA).
After normalisation, the fold-change (FC) expression was calcu-
lated between Ecad-/- grown in LIF and wtD3 ES cells and
between Ecad-/- ES cells cultured in the presence and absence of
LIF. Differential expression analysis was performed using Limma
using the functions lmFit and eBayes [24] and false discovery rate
(fdr) errors controlled using the method of QVALUE [25]. A q
value (q,0.050) and the fold-change threshold FC$2.50 was
chosen to identify the statistically significant transcript alterations.
The website DAVID was used to analyse the enrichment in the
Gene Onthology (GO) terms and KEGG Pathway terms among
the statistically significant genes between Ecad-/- and wtD3 ES
cells [26,27]. The software GO-Elite was used to analyse the
Wikipathways represented in the statistically significant gene list (z
score $2.0) (www.genmapp.org/go_elite). The microarray data is
published in ArrayExpress, accession number E-MEXP-2836, and
all data is MIAME compliant. Agilent array platform data for
EpiSCs [28] was obtained from GEO (GSE7902-GPL4134). The
raw data was quantile normalised and differential expression
assessed between ES and post-ES groups by t-test and fdr by
QVALUE using Partek Genomics Solution (version 6.5, Copy-
right 2005, Partek Inc.). Data was merged with our dataset using
the gene symbol annotation using the Galaxy platform [29]. Both
array platforms have multiple measurements for some genes.
Where this was the case, the measurement showing the most
highly significant p-value in differential expression was used in
merging the data.
RT-PCR
Total RNA was extracted from cells using Trizol (Sigma)
according to the manufacturer’s instructions, treated with DNase
(Promega) and phenol/chloroform purified. Synthesis of cDNA
was performed as described previously [30]. RT-PCR was
performed using 1 ml of the cDNA solution and amplified for 30
cycles at optimal annealing temperature. Samples were separated
on 2% (w/v) agarose gels containing 400 ng/ml ethidium bromide
and visualised using a UV transilluminator. Primer sequences are
shown in Table S1.
qPCR
Quantitative PCR was used to confirm the microarray results.
Expression of genes related to EpiS cells was analysed using MRP
L19 as a housekeeping gene. The qPCR primers were designed
using the Universal Probe Library software on the Roche Applied
Science website. cDNA was made from 2 mg of RNA, as
previously described [17], and diluted 1:100 with nuclease-free
water for qPCR amplification. Each cDNA sample/primer set
combination was run in triplicate in 96-well MicroAmp Optical
reaction plates (Applied Biosystems, Warrington, UK). Mouse
genomic DNA (gDNA, Bioline, London, UK) was used as positive
control whilst water and the –RT reaction were used to check for
false-positives and contaminants on each sample using MRP L19.
Primer sequences are shown in Table S2. Three independent
RNA samples were analysed for both wtD3 and Ecad-/- ES cells.
A typical qPCR reaction contained: 5 ml of diluted cDNA,
0.075 ml of each forward and reverse primer at 100 mM
concentration stock, 12.5 ml Power SYBR Green PCR Master
Mix (AB Applied Biosystems, Warrington, UK) and 7.35 ml
nuclease-free water. The qPCR reaction was performed on a 7300
Real Time PCR System (AB Applied Biosystems, Warrington,
UK) and comprised 40 cycles of PCR at 60uC annealing
temperature and at the end the dissociation curve stage was
performed. The Ct values were exported into a Microsoft Excel
Spreadsheet and analysed according to the DCt system. The –
DDCt (Ecad-/-vs wtD3) values were plotted to show the genes that
are up or downregulated in Ecad-/- ES cells compared to wtD3
ES cells.
Results
LIF supplementation does not significantly alter the
transcript profile of Ecad-/- ES cells
We have previously shown that Ecad-/- ES cells maintain
expression of the pluripotency markers Nanog, Sox2 and Oct3/4
via Activin/Nodal signalling pathways in FBS-containing medium,
irrespective of LIF supplementation [17]. Therefore, to determine
the effect of LIF on these cells we compared gene expression
profiles of Ecad-/- ES cells cultured in the presence or absence of
LIF (ArrayExpress E-MEXP-2836). PCA of the microarray data
confirmed the quality of the triplicate samples (Figure S1) and
hierarchical clustering analysis identified that the main variation
within the data sets was between wtD3 and Ecad-/- ES cells
(Figure 1A). No clustering could differentiate between Ecad-/- ES
cells grown in the presence and absence of LIF and any variation
among these samples can be classified within the normal biological
variance. These results suggest that LIF has little or no effect on
gene expression profiles of Ecad-/- ES cells despite the LIF
receptor and gp130 being localised at the cell surface (KH,
unpublished data). Threshold levels of q,0.05 and fold-change
(FC) $2.50 were chosen to determine statistical significance
between transcript levels. Only 2 genes among over 45,000 probes
were found to be statistically significant in Ecad-/- ES cells grown
with or without LIF (Figure 1B). The trans-acting transcription
factor 8 (Sp8) showed a 6.2-fold increase in the absence of LIF
whereas the signal transducer and activator of transcription 3
(Stat3) was downregulated 3.4-fold. This observation suggests that
Stat3 and Sp8 transcripts are likely to be regulated by LIF
independently of E-cadherin and that LIF-mediated Stat3
activation is dispensable for Ecad-/- ES cell pluripotency.
wtD3 and Ecad-/- ES cells exhibit distinct gene
expression profiles
Comparison of transcript expression in wtD3 and Ecad-/- ES
cells cultured in the presence of LIF revealed 2768 probes,
representing 2265 genes, which were differentially expressed.
Ecad-/- ES cells showed a slight bias towards downregulation of
genes compared to wtD3 ES cells (55% downregulated in the
former). Analysis of the magnitude of fold-change in gene
expression revealed that the majority of upregulated genes in
Ecad-/- ES cells fell between 2.5 and 10 fold-change (88% of total
upregulated genes) whilst 12% were between 10 and 100FC
(Figure 1C). Only 1 gene (Serpina3m, representing 0.01%)
resulted in a positive fold-change above 100 (+165FC). Amongst
the twenty most upregulated genes (Table 1), six were known
glycoproteins and two were members of the Serpin family (a3m
and b9), which are peptidase inhibitors with anti-apoptotic
activity. With respect to downregulated genes in Ecad-/- ES cells,
74% exhibited a fold-change of -2.5 to -10, 23% showed a fold-
change between -10 and -100 and 3% (46 genes) showed over 100-
Global Transcript Alterations in Ecad-/- ES Cells
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twenty most downregulated genes (Table 2), 5 genes exhibited
over 500-fold change and were mainly associated with gene
expression regulation and transcription factor activity, such as
Pycard. Overall, this data shows that inhibition of E-cadherin
results in significant global gene transcript alterations, suggesting
that E-cadherin plays a critical role in regulating the transcrip-
tional phenotype of mES cells.
Gene Ontology (GO) (Figures 2A and 3A), KEGG pathway
(Figure S2 and Table S3) and WikiPathway analysis (Figure 2B
and 3B) of the 2265 differentially expressed genes were performed
using the web-based software DAVID and GO-Elite. The GO
analysis revealed that depletion of E-cadherin at the cell surface of
mouse ES cells did not exclusively affect adhesion-associated
transcripts (e.g. cell adhesion, cell migration) but had a wider
transcriptional impact as shown by GO terms such as ‘‘primary
metabolic process’’ and ‘‘catalytic activity’’. The ten most up- and
down-regulated genes in Ecad-/- ES cells in each of the GO terms
(compared to wtD3) are shown in Figure 3A. The ‘‘primary
metabolic process’’ group contained 807 genes representing 36%
of the total gene list. Within this group, we found alterations in
transcript expression of regulators of transcription (Esrrb, Nr0b1,
Zfp42), signalling transducer/regulator molecules (Inhbb, Calcr,
Fst) as well as genes related to protein phosphorylation (Epha1)
and degradation (Pycard). Many of these genes appeared in other
more specific GO categories (Figure 3A). Alterations in genes
associated with catalytic activities included kinases (Hck, Epha1),
hydrolases (Ddx4) and transferases involved in post-translational
modifications, such as sulfotransferases (Chst1) and sialyltrans-
ferases (St8sia4). 14% of the transcript alterations were related to
‘‘multicellular organismal development’’ and 12% to ‘‘cell
differentiation’’, comprising genes involved in sex determination
(Nr0b1, Morc1, Fst and Rnf17) and neuronal development (Nefm,
Galr2), amongst others. Ecad-/- ES cells also exhibited down-
regulation of genes associated with maintenance of ES cell
pluripotency such as Nr0b1 and Tbx3 and up-regulation of
proliferative genes (e.g. Fgf-5). The alteration in gene transcripts
involved in regulation of cell cycle and apoptosis confirm our
previous observations that Ecad-/- ES cells exhibit nearly 2-fold
increased proliferation compared to wtD3 ES cells (Figure S3A)
Figure 1. Ecad-/- ES cell expression profile is distinct from wtD3 ES cells irrespective of LIF-supplementation. RNA microarray analysis
of gene expression was performed on wtD3 and Ecad-/- ES cells cultured in standard conditions in the presence of LIF and Ecad-/- ES cells cultured for
12 days in the absence of LIF. RNA was collected in three independent experiments for each cell line/condition. A. Dendrogram demonstrating
clustering analysis of the microarray data for wtD3 (red), Ecad-/- (blue) and Ecad-/- -LIF (green) ES cells. B. Table showing the two genes that exhibited
differential expression between Ecad-/- ES cells cultured in the presence and absence of LIF. Results were deemed significantly different if the q value
was ,0.05 and fold change $2.50. C. Analysis of fold change values of genes upregulated in Ecad-/- ES cells compared to wtD3 ES cells. Upregulated
genes were fewer in number and fold change absolute values were lower in comparison to downregulated genes. 88% of the genes showed FC
between 2.5 and 10, 11.99% had a FC between 10 and 100 and only 1 (0.01%) exhibited FC.100 D. Analysis of fold change values of genes
downregulated in Ecad-/- ES cells compared to wtD3 ES cells. The absolute value of FC of downregulated genes was higher than the upregulated
ones. 0.01% of genes had a FC below -500, 2.99% between -500 and -100, 23% exhibited FC between -100 and -10 whilst the larger proportion (73%)
showed FC between -10 and -2.5. Data published in ArrayExpress E-MEXP-2836.
doi:10.1371/journal.pone.0021463.g001
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Gene Accession No. Common Name FC q value
Serpina3m BC011158 Serine (or cysteine) peptidase inhibitor, clade A, member 3M +165 ,0.0001
Cd59a NM_007652 CD59a antigen +66 ,0.0001
Btla BM240873 B and T lymphocyte associated +64 ,0.0001
Nefm NM_008691 Neurofilament, medium polypeptide +62 ,0.0001
Serpinb9 NM_009256 Serine (or cysteine) peptidase inhibitor, clade B, member 9 +61 ,0.0001
Slc39a8 NM_026228 Solute carrier family 39 (metal ion transporter), member 8 +55 ,0.0001
Fgf5 AV240088 Fibroblast growth factor 5 +52 ,0.0001
Psors1c2 NM_020576 Psoriasis susceptibility 1 candidate 2 (human) +50 ,0.0001
BC064078 AW493518 cDNA sequence BC064078 +46 ,0.0001
Epha1 NM_023580 Eph receptor A1 +40 ,0.0001
Irgm NM_008326 Immunity-related GTPase family, M +38 0.001
-- W45978 cDNA clone IMAGE:1328649 +38 0.002
Fst NM_008046 Follistatin +38 ,0.0001
Il33 NM_133775 Interleukin 33 +36 ,0.0001
Mfap3l AK017269 Microfibrillar-associated protein 3-like +35 0.007
Chst1 NM_023850 Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 +34 0.001
Galr2 NM_010254 Galanin receptor 2 +31 ,0.0001
Gpr37 BQ175510 G protein-coupled receptor 37 +29 ,0.0001
Cd44 M27130 CD44 antigen +28 ,0.0001
Cd59a AK005507 CD59a antigen +27 ,0.0001
(FC=fold-change).
doi:10.1371/journal.pone.0021463.t001
Table 2. List of the top 20 downregulated transcripts in Ecad-/- ES cells.
Gene Accession No. Common Name FC q value
EG653016 AV101904 Predicted gene 2752 ,0.0001
4930517K11Rik AK005645 RIKEN cDNA 2712 ,0.0001
Esrrb AV333667 Estrogen related receptor, beta 2579 ,0.0001
Inhbb BB253137 Inhibin beta-B 2546 ,0.0001
Laptm5 BB218107 lysosomal-associated protein transmembrane 5 2527 ,0.0001
Nr0b1/Dax1 NM_007430 Nuclear receptor subfamily 0, group B, member 1 2450 ,0.0001
Pycard BG084230 PYD and CARD domain containing 2449 ,0.0001
Lgals3 X16834 Lectin, galactose binding, soluble 3 2445 ,0.0001
Calml4 AY061807 Calmodulin-like 4 2402 ,0.0001
Zfp42/Rex1 NM_009556 Zinc finger protein 42 2353 ,0.0001
Slc38a4 AK003626 Solute carrier family 38, member 4 2310 ,0.0001
Rnf17 AV225034 Ring finger protein 17 2286 ,0.0001
Mras AB004879 Muscle and microspikes RAS 2280 ,0.0001
LOC245128 AV099404 Similar to solute carrier family 7, member 3 2266 ,0.0001
Lrrc34 AK005720 Leucine rich repeat containing 34 2260 ,0.0001
Slc38a4 NM_027052 Solute carrier family 38, member 4 2259 ,0.0001
2410146L05Rik BB702364 RIKEN cDNA 2410146L05 gene 2256 ,0.0001
Tgfbi BB533460 Transforming growth factor, beta induced 2255 ,0.0001
-- BG071670 Transcribed locus 2252 ,0.0001
Dppa5 NM_025274 Developmental pluripotency associated 5 2247 ,0.0001
(FC=fold-change).
doi:10.1371/journal.pone.0021463.t002
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between the proportion of cells in G1, S or G2 phase between
wtD3 and Ecad-/- ES cells (Figure S3B), suggesting that increased
proliferation of Ecad-/- ES cells is not due to altered cell cycle
kinetics. Approximately 23% of the genes were not associated with
any GO term and 19% were associated with GO groups
containing less than 10 genes. The analysis of the pathways with
the most enriched number of terms using the KEGG database
confirmed the influence of E-cadherin on primary metabolic
processes (Figure 2A). Six of the 20 terms (30%) were associated
with metabolic pathways, in particular of carbohydrates
(mmu00520 and mmu00051), lipid (mmu565 and mmu00071)
and amino acids (mmu00310 and mmu00480) (Figure S2 and
Table S3). Three terms were associated with cell communication
and adhesion (mmu04510, mmu04530 and mmu04540) and one
with the interaction of the cell with the extra-cellular matrix
(mmu04512). These terms may reflect the influence of E-cadherin
on cell adhesion and the single cell morphology observed in
Ecad-/- ES cells.
G0-Elite software analysis identified altered pathways in
Ecad-/- ES cells associated with embryonic stem cell pluripotency
(Figures 2B and 3B). The PluriNetWork (WP1763), which
comprises an intricate network of genes and mechanisms
underlying mouse pluripotency, exhibited 70 altered transcripts
(Figure 2B). The top 10 up- and down-regulated transcripts
associated with the PluriNetWork and ES pluripotency pathways
are shown in Figure 3B. A detailed analysis of transcript alterations
associated with the mouse ES cell pluripotency network is shown
in Figure 3C. Alterations in transcript expression were observed in
a range of pluripotency-associated signalling pathways including
LIF, Ras/Erk, FGF, PI3K, and BMPs (Figure 3C). Whilst
transcripts encoding the LIF receptor and its complex partner
gp130 (Il6st) were down-regulated, both proteins are present at the
cell surface of Ecad-/- ES cells (KH, data not shown). This
suggests that the alteration in pluripotency pathways in Ecad-/-
ES cells is not a result of absence of these receptors at the cell
surface. BMP4 encoding transcripts were decreased 79-fold
compared to wtD3 ES cells and this may reflect the dependency
of Ecad-/- ES cells on Activin/Nodal signalling, rather than LIF/
BMP [17]. However, it should be noted that Ecad-/- ES cells are
able to maintain pluripotency in LIF/BMP-supplemented medium
in the absence of Activin/Nodal, suggesting that an alteration in
pluripotency pathway hierarchy occurs in these cells, rather than
an irreversible switch from LIF/BMP to the Activin/Nodal
pathways [17]. We have previously demonstrated that Ecad-/-
ES cells exhibit increased proliferation via FGF2 [17]. Although
neither FGF2 nor its receptor (FGFR1) exhibited altered transcript
expression in Ecad-/- ES cells, different ligands of the same family
(e.g. FGF5) showed modified expression levels. Whilst the ES cell
pluripotency transcript analyses reflect our previous observation
that the LIF/BMP pathways are altered in Ecad-/- ES cells they
do not, frustratingly, provide a definitive explanation for the
dependence of these cells on Activin/Nodal and FGF2 signalling.
However, up-regulation of the natural inhibitor of Activin A,
Follistatin (FC = +38, Table 1), provides circumstantial evidence
for the altered regulation of the Activin/Nodal pathway in Ecad-/-
ES cells. Overall, these results show that Ecad-/- ES cells exhibit a
distinct gene expression profile compared to wtD3, with variations
associated with a large variety of biological processes, including
alterations in pluripotency pathways.
The Ecad-/- ES cell transcriptome exhibits more similarity
with the epiblast-derived stem cell transcriptome than
wtES cells
Pluripotent cells derived from the epiblast tissue of embryos
(EpiS cells) [28,31] have been described to self-renew via the
Activin/Nodal pathway using FGF as a proliferative factor in a
similar manner to Ecad-/- ES cells, previously described by our
group [17]. Therefore, we investigated the similarities in transcript
expression between Ecad-/- ES cells and EpiS cells according to
available published data [28,31]. We also compared the transcript
expression of FABS cells, stem cells derived from mouse ICM
using a chemically defined medium containing FGF2, Activin,
Figure 2. Gene Ontology and G0-Elite analysis. Pie chart showing the gene ontology terms that are most represented in the microarray analysis
comparing wtD3 and Ecad-/- ES cells (A). Besides terms related to loss of cell adhesion (cell migration and cytoskeleton protein binding), the most
represented genes belong to general biological processes such as primary metabolic processes (36%; representing 807 genes) and catalytic activity
(28%; 625 genes). A large number of genes are also associated with cell differentiation (12%; 279 genes) and multicellular organismal development
(14%; 320 genes). These results suggest that E-cadherin mediated cell-cell adhesion does not solely control the migratory ability of the cell but affects
more general aspects of cellular biology. The numbers inside each pie slice show the percentage of total differentially expressed genes. B. G0-Elite
analysis of Wikipathways. Networks associated with pluripotency are highly represented.
doi:10.1371/journal.pone.0021463.g002
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5 and down-regulation of Zfp42/Rex1 and Nr0b1 have been
described as signature markers of EpiS cells [28,31] and this was
shared between all cell lines in addition to increased levels of
Eomes transcripts (Figures 4A and 4B; Figure S5). In addition,
transcripts encoding CRTR1, Klf4, Piwil2, Gbx2, Dazl and
Fbx015 were all down-regulated in Ecad-/- and EpiS cells
(Figures 4A and 4B; Figure S5). Tdgf1, Myc and Sox2 showed
no gene expression changes in the target cell lines (Figure 4A and
4B). Despite the similarity in core gene transcript expression
between Ecad-/- and EpiS cells, hierarchical analysis of the data
sets demonstrated that the cell lines exhibit distinct transcript
expression patterns (Figure 4C). However, the Ecad-/- ES cell
transcriptome exhibits more similarity with EpiS cells than wtES
cells, demonstrating that Ecad-/- ES cells are more closely related
to an epiblast phenotype than that of the ICM. Tables S4, S5, S6
and S7 compare the top 20 up- and down-regulated genes in
Ecad-/- and EpiSCs to further illustrate the similarities and
differences in transcript expression between these two cell lines.
For example, whilst there is a significant degree of similarity in the
trend of downregulated transcripts, this is less apparent in
upregulated transcripts. Overall, these results demonstrate that
whilst Ecad-/- ES cells share similar transcriptional traits with
EpiS cells they are a distinct cell type with a unique transcriptional
signature.
Ecad-/- ES cells do not exhibit endogenous b-catenin/TCF
activity
Since E-cadherin can sequester b-catenin at the cell surface,
potentially regulating the amount of b-catenin available for
canonical Wnt transactivation, we decided to investigate the levels
of b-catenin-mediated nuclear activity in Ecad-/- ES cells. Whilst
our previous data suggested no fundamental role for canonical
Wnt pathway in the maintenance of ES cell pluripotency [17] we
Figure 3. List of the top 10 upregulated and downregulated genes represented in the Gene Ontology analysis. List of the top 10 up-
regulated (green) and down-regulated (red) genes (A) in each of the GO terms shown in Figure 2A. B. List of the top 10 up-regulated (green) and
down-regulated (red) genes in the PluriNetWork and ESC Pluripotency pathways shown in Figure 2B. C. Network of transcripts associated with the
ESC Pluripotency Pathway. Transcripts exhibiting altered expression in Ecad-/- ES cells are highlighted: upregulated transcripts are shown in green
and downregulated transcripts shown in red (with fold-change indicated by the number). Reproduced with kind permission from WikiPathways
(http://creativecommons.org/licenses/by/3.0/).
doi:10.1371/journal.pone.0021463.g003
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the impact of b-catenin in regulating non-pluripotency associated
transcripts. One of the most represented signalling pathways in the
Ecad-/- ES cell array highlighted by KEGG and WikiPathway
analysis was the Wnt pathway (Figures 2B, S4 and Tables 2A and
S3). Analysis of gene transcript changes associated with the Wnt
pathway demonstrated alteration in transcripts encoding ligands,
receptors and antagonists (Table 3 and Figure S4). Whilst almost
every aspect of the Wnt-pathway is represented, some elements are
upregulated (e.g. Fzd1, 2, Wnt5b, Wnt8a, TCF7, LEF1) whilst
others are downregulated (e.g. Fzd5, Wnt7b, TCF15). In addition,
some elements of the b-catenin degradation pathway are increased
(e.g. Axin2, Snk1d) whereas others are decreased (e.g. Ppp2r5a).
This data suggests that E-cadherin functions to both positively-
and negatively-regulate the Wnt pathway and associated tran-
scripts. Analysis of b-catenin/TCF target genes revealed that of
the 40 genes assessed 73% exhibited no significant alteration in
Ecad-/- compared to wtES cells (Table 4). Whilst six b-catenin-
transactivated transcripts were upregulated in Ecad-/- ES cells,
four were downregulated, suggesting divergent b-catenin/TCF-
induced gene transactivation.
To determine b-catenin/TCF activity in Ecad-/- ES cells we
investigated levels of b-catenin-mediated transactivation in
Ecad-/- ES cells compared to wtD3 ES cells using the reporter
plasmid TOPflash. TOPflash contains the firefly luciferase gene
under the control of several repeats of the b-catenin/TCF
promoter region, whilst the control plasmid FOPflash contains a
mutated version of the same promoter. As previously reported
[13,14], wtD3 ES cells lacked b-catenin/TCF activity, as
demonstrated by similar levels of luciferase activity of both
TOPflash and FOPflash plasmids (Figure 5A, blue bars). Ecad-/-
ES cells also exhibited very low levels of TOPflash expression in
LIF-supplemented medium with a slightly higher level observed
for FOPflash (Figure 5B, blue bars), demonstrating lack of b-
catenin/TCF activity in these cells. To investigate the ability of the
cells to activate b-catenin-mediated gene expression in response to
Wnt-like stimuli, both wtD3 and Ecad-/- ES cells were treated
with the small molecule BIO, an inhibitor of GSK3, or with
equivalent volumes of DMSO (control). Whilst BIO is not a
specific Wnt activator, the presence of b-catenin/TCF promoter
repeats within the TOPflash vector, and mutated regions in the
FOPflash vector, enable the specificity of b-catenin/TCF activity
to be assessed. WtD3 ES cells showed a dose-dependent TOPflash
response to BIO (Figure 5A, light and dark green bars) which was
significantly higher than the DMSO control (Figure 5A, red bar).
The mutated reporter plasmid, FOPflash, did not exhibit
differential activation in wtD3 ES cells in the presence of either
DMSO (Figure 5A, red bar) or BIO (Figure 5A, light and dark
green bars). Ecad-/- ES cells also exhibited a dose-dependent
increase in TOPflash response to BIO (Figure 5B, light and dark
green bars) compared to the control DMSO (Figure 5B, red bar).
FOPflash did not exhibit differential activity in Ecad-/- ES cells in
Figure 4. Ecad-/- ES cells show more transcriptional similarities to EpiS cells than to the parental wtES cell line. Table showing genes
with similar expression patterns in Ecad-/-, EpiSC and FABS cells compared to wtES cells (A). The last column of the table shows the fold-change (FC)
calculated in our microarray analysis. NS = Not Significant. B. Validation of the microarray data by RT-PCR. FGF-5 (upregulated), Rex1, CRTR1, Dax1,
Dazl, Fbx015 and Klf4 (downregulated) and the unchanged genes Tdgf1 and Myc confirmed the microarray results. C. Dendrogram generated by
hierarchical clustering of the microarray data for wtD3, Ecad-/- and EpiSCs (Brons et al. (2007) [28]). Data for EpiS and FABS cells were taken from
Brons et al. (2007) [28] and Chou et al. (2008) [16].
doi:10.1371/journal.pone.0021463.g004
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bars).
To confirm the TOPflash analysis, we assessed the expression
of the mesoderm marker Brachyury (T), which has been reported
to be regulated via b-catenin/TCF transactivation [2]. Whilst
Brachyury was not detected in wtD3 or Ecad-/- ES cells by RT-
PCR, treatment of these cells with BIO resulted in upregulation
of transcripts in both cell lines (Figure 5C). Similar results were
also observed in Ecad-/- cells cultured with BIO in the absence of
LIF (data not shown). These data demonstrate that Ecad-/- ES
cells exhibit very low levels of b-catenin/TCF transactivation,
similar to that observed in wtD3 ES cells. Overall, these results
suggest that loss of E-cadherin in ES cells does not induce b-
catenin/TCF transactivation, in contrast to previously published
data [2]. Moreover, the data also suggests that a pool of b-catenin
protein is present within Ecad-/- ES cells which is able to re-
spond to Wnt stimuli, as demonstrated by dose-dependent BIO
activation.
Ecad-/- ES cells exhibit reduced b-catenin protein levels
compared to wtD3 ES cells
Since Ecad-/- ES cells exhibited negligible b-catenin/TCF
transactivation, we investigated the levels of compartmentalised b-
catenin protein in these cells compared to wtD3 ES cells (Figure 6).
b-catenin protein was detected in wtD3 and Ecad-/- ES cells using
immunofluorescent microscopy analysis (Figure 6A) and quantified
using the Arrayscan compartmental analysis algorithm by Imagen
Biotech (Manchester, UK). Ecad-/- ES cells showed approxi-
mately 50% lower levels of total b-catenin protein compared to
wtD3 ES cells (Figure 6B, red and blue histogram, respectively). In
wtD3 ES cells, b-catenin was mainly localised at the cell
membrane (Figure 6A and 6B, blue histogram). In contrast,
Ecad-/- ES cells grown in standard LIF medium exhibited diffuse
b-catenin protein throughout the cytoplasm with some cells
showing nuclear localisation (shown by arrows in Figure 6A).
Quantification of the protein expression levels revealed similar
distribution of the protein between the membrane/cytoplasm and
the nucleus of Ecad-/- ES cells (Figure 6B, red bars). No significant
differences in b-catenin localisation or expression were observed
between Ecad-/- ES cells cultured in the presence or absence of
LIF (Figure 6B, red and green histogram, respectively). Overall,
this data shows that Ecad-/- ES cells exhibit significantly
decreased levels of membrane/cytoplasmic b-catenin compared
to wtD3 ES cells whereas nuclear b-catenin levels are similar in
both cell lines. To confirm that the levels of b-catenin protein are
affected by E-cadherin, we performed the same quantification
assay in EcadRNAi ES cells, where E-cadherin protein expression
is inhibited by siRNA plasmids and in EcadRNAiR, a rescued cell
line where the siRNA effect is silenced thus restoring normal levels
of E-cadherin expression [17]. The assay showed significantly
lower levels of total b-catenin protein in EcadRNAi cells
compared to EcadRNAiR cells (Figure 6C, red and blue bars,
respectively), whereas no significant difference in expression levels
were observed in EcadRNAi cells cultured in the presence or
absence of LIF (Figure 6C, red and green bars, respectively). In
EcadRNAi cells, grown in either the presence or absence of LIF,
b-catenin was mainly localised within the nucleus (Figure 6C, red
and green bars, respectively). In contrast, the rescued cell line
EcadRNAiR showed high levels of b-catenin protein in the
membrane+cytoplasm compartment (Figure 6C, blue histogram).
These results suggest that E-cadherin expression may act as
positive regulator of total b-catenin protein levels in mouse ES
cells.







NM_009525 Wnt5b 8.31 AI323642 Tcf7 2.63
W29605 Wnt7b 23.36 NM_009328 Tcf15 28.89
NM_009290 Wnt8a 21.59 NM_010703 Lef1 5.90
Receptors BG073323 Chd8 24.15
BB259670 Fzd1 11.64 Other
BB371406 Fzd2 13.25 AB036749 Porcn 27.85
AU043193 Fzd3 22.62 BB353860 Frat2 23.19
NM_022721 Fzd5 222.22 BC006875 Prkx 2.89
NM_008056 Fzd6 3.54 Non-canonical Wnt pathway
Antagonist NM_008874 Plcb3 24.85
BB497685 Sfrp1 22.52 BM730668 Plcb4 24.10
NM_009144 Sfrp2 7.91 AW490258 Camk2a 22.85
b-Catenin degradation machinery NM_007595 Camk2b 23.06










M36277 Mycn NS NM_010919 Nkx2-2 NS
NM_007865 Dll1 NS NM_018865 Wisp1 NS
NM_008238 Foxn1 NS NM_016873 Wisp2 NS
NM_011427 Snai1 NS X75557 Mrpplf3 NS
BM234360 Fn1 26.12 U25633 Emp1 2116.90
BQ176915 Isl1 NS NM_010512 Igf1 NS
NM_009291 Stra6 NS NM_009506 Vegfc 220.48
NM_009404 Tnfsf9 NS NM_011075 Abcb1b NS
NM_010110 Efnb1 NS NM_031168 Il6 NS
BC003264 Enpp2 16.83 BC019986 Cdx1 NS
NM_012043 Islr NS NM_007674 Cdx4 NS
NM_010809 Mmp3 NS NM_009144 Sfrp2 7.91
NM_009309 T* 4.35 AB006320 Pitx2 NS
NM_007541 Bglap1-2 NS U03425 Egfr 4.98
BC019986 Cdx1 NS NM_010099 Eda NS
M94967 Ptgs2 NS BC021411 Ovol1 NS
NM_008393 Irx3 NS AV359819 Jag1 NS**
D83144 Six3 NS NM_009877 Cdkn2a NS
NM_010896 Neurog1 NS BB709552 Fgf4 24.76
NM_022435 Sp5 6.79 NM_013869 Tnfrsf19 3.33
*Not significant by RT-PCR.
**FC=2.3, q,0.05. NS according to our threshold of FC$2.50.
doi:10.1371/journal.pone.0021463.t004
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PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e21463Figure 5. Ecad-/- ES cells show low basal Wnt activity similar to wtD3 ES cells. TOPflash and FOPflash reporter plasmid expression (A)i n
wtD3 ES cells cultured in LIF-supplemented standard medium (blue bar), DMSO control (red bar), 1 mM BIO (light green bar) and 2 mM BIO (dark green
bar). B. TOPflash and FOPflash reporter plasmid expression in Ecad-/- ES cells cultured in LIF-supplemented standard medium (blue bar), DMSO
control (red bar), 1 mM BIO (light green bar) and 2 mM BIO (dark green bar). C. RT-PCR expression of Brachyury (T), a typical Wnt activity marker, in
wtD3 and Ecad-/- ES cells grown in the presence (+) and absence (2)o f2mM BIO. bt=b-tubulin (loading control). Results present mean 6 SD of one
single experiment. At least, three independent experiments were performed.
doi:10.1371/journal.pone.0021463.g005
Figure 6. E-cadherin-depleted ES cells exhibit lower b-catenin protein levels compared to parental ES cells. Immunoflurescence
microscopy images of b-catenin protein expression in wtD3 and Ecad-/- ES cells (A). Red arrows show nuclear localisation of b-catenin protein in
Ecad-/- ES cells. B. Total and compartmental quantification of b-Catenin protein in wtD3 (blue) and Ecad-/- (red) ES cells cultured in LIF and Ecad-/- ES
cells cultured in the absence of LIF (green). Error bars represent standard error of the mean of three independent experiments. C. wtES cells were
transfected with an E-cadherin targeting hairpin-loop RNAi vector (RNAi) to derive clones lacking E-cadherin protein expression [17]. E-cadherin
expression in the RNAi clone was subsequently induced by inhibition of the RNAi vector (RNAiR [17]). Total and compartmental quantification of b-
catenin protein expression in RNAiR (blue) and RNAi (red) ES cells cultured in the presence of LIF and RNAi ES cells cultured in the absence of LIF
(green) are shown. Similar to Ecad-/- ES cells, RNAi ES cells showed lower level of total b-catenin proteins compared to the rescued cell line RNAiR (red
and blue, respectively). Error bars represent standard error of the mean of three independent experiments.
doi:10.1371/journal.pone.0021463.g006
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We have previously shown that Ecad-/- ES cells exhibit altered
response to exogenous factors, maintaining pluripotency marker
expression via the Activin/Nodal pathways and optimal self-
renewal via FGF2 [17]. In this study, we have examined and
compared the gene expression profiles of wtD3 and Ecad-/- ES
cells cultured in standard LIF conditions and those of Ecad-/- ES
cells cultured in the absence of LIF by Affymetrix microarray
analysis.
Our data show that LIF exerts limited influence on the gene
expression profile of Ecad-/- ES cells as demonstrated by the near
identical transcript profiles obtained from these cells cultured in
the presence or absence of LIF. Of over 45,000 probes assessed,
only 2 genes showed statistically significant differences in transcript
expression, Sp8 and Stat3. The transcription factor Sp8, which
was upregulated 6.2-fold in the absence of LIF, has been reported
to be critical during the formation of the apical ectodermal ridge
for the correct outgrowth of limbs and proper closure of the cranial
box. Research has suggested that Sp8 works downstream of the
Wnt3, Fgf and BmpR cascades that regulate this phase of embryo
development [32,33]. However, no function in ES cells has been
attributed to Sp8. Stat3, which showed 3.4-fold decreased
expression in Ecad-/- ES cells in the absence of LIF, can be
activated by various cytokines and is responsible for the
transduction of LIF-mediated signals in the maintenance of
pluripotency in mES cells. Interestingly, recent studies suggest
the presence of positive feedback between LIF activity and Stat3
transcript levels [34,35,36]. Therefore, Stat3 downregulation in
Ecad-/- ES cultured in the absence of LIF suggests that these cells
exhibit a minimal response to LIF. This hypothesis is corroborated
by the down-regulation of LIFR and gp130 (Ilst6) even in the
presence of LIF within the culture media.
The previously observed LIF-independent pluripotency of
Ecad-/- ES cells was confirmed by the down-regulation of Socs3,
Tbx3 and Klf4, in the presence or absence of LIF. Tbx3 and Klf4
have recently been identified as down-stream effectors of two
parallel circuitries of the LIF pathway [35] whilst Socs3 has been
reported as a direct target of Stat3 [37]. As suggested by Niwa and
colleagues [35], the function of certain genes, such as Tbx3 and
Klf4, might be strictly cellular context-related and different gene
sets might be associated with various extracellular signals to
converge in the maintenance of the same core of transcription
factors (e.g. Nanog, Sox2, Oct3/4). Recent studies have reported
the ability of the Smad2/3 pathway, activated via activins, to
sustain Nanog expression in EpiS cells [38]. We have previously
demonstrated that inhibition of this pathway in Ecad-/- ES cells
causes rapid differentiation of the cells with loss of Nanog
expression [17]. We have also observed that Ecad-/- ES cells
can be cultured in LIF/BMP medium and that wtES cells exhibit
reversible Activin/Nodal-dependent pluripotency when treated
with an E-cadherin inhibiting peptide [17]. This suggests that the
maintenance of pluripotency via extrinsic factors is likely to be
more complex than previously described, with E-cadherin playing
a pivotal role in regulating hierarchical signalling via the LIF/
BMP and Activin/Nodal pathways. Whilst the core transcription
factors associated with pluripotency are expressed in Ecad-/- ES
cells, the pathways which regulate these factors are clearly different
to wtES cells. For example, it is likely that Ecad-/- ES cells
maintain pluripotency via Smad2/3-induced transactivation of
target genes rather than the signalling networks currently
attributed to mouse ES cells. It has been previously demonstrated
that ES cells exhibit an innate ability for replication that does not
appear to require intercellular stimulation and is intrinsically self-
maintaining, akin to that observed in unicellular organisms [39].
Our results suggest that this pluripotent ‘ground state’ is unaltered
in Ecad-/- ES cells and that the function of E-cadherin is to
regulate extrinsic stimuli that converge to maintain expression of
the core pluripotency-associated transcripts Oct3/4, Nanog and
Sox2.
The observation of the similarities between Ecad-/- ES, EpiS
and FABS cells raises interesting questions about the impact of E-
cadherin on gene expression. Hierarchical analysis of the array
data showed that Ecad-/- ES cells exhibit more similarities with
EpiS cells than wtES cells. The question is whether, and how,
some of the transcriptional similarities between Ecad-/- ES and
EpiS/FABS cells are mediated by E-cadherin protein expression.
Although E-cadherin protein levels in EpiS cells have not been
described, a correlation has been reported in FABS cells [16].
FABS cells exhibited low levels of E-cadherin transcript and
protein and showed low chimerism and teratoma formation ability
together with limited proliferation when cultured in suspension.
However, upon LIF/BMP4 stimulation, FABS cells up-regulated
E-cadherin and showed improved chimerism ability and teratoma
formation. These features were maintained upon reversal of the
growth conditions to FABS cell media which was associated with
the maintenance of E-cadherin expression.
It has been previously reported that Ecad-/- ES cells exhibit
increased levels of brachyury transcripts and that this is achieved
by b-catenin/TCF-induced gene transactivation [2,40]. However,
our analysis of Ecad-/- ES cells has failed to confirm these
observations. The decreased expression of total b-catenin protein
in both Ecad-/- and EcadRNAi ES cells does not correlate with b-
catenin transcript expression in these cells, suggesting that E-
cadherin may stabilise b-catenin protein levels in wtES cells.
Although the nuclear to membrane/cytoplasmic ratio of b-catenin
in Ecad-/- ES cells was higher than that observed in wtD3 ES
cells, the quantity of protein localised within the nucleus was
similar in both cell lines. These results suggest that the pool of b-
catenin normally recruited at the cell surface by E-cadherin is
almost entirely degraded and a new homeostatic equilibrium is
achieved in E-cadherin-depleted cells, resulting in lower total b-
catenin protein levels. This hypothesis is corroborated by the
increased levels of b-catenin protein measured in the rescued
EcadRNAiR ES cell line. Our data also support the hypothesis
that b-catenin exists within cells in two discrete forms, one with
high cell adhesion specificity and another for nuclear signalling
and that these two forms are not completely interchangeable [41].
These results are also in accordance with the mathematical model
presented by van Leeuwen and colleagues [42], which expanded
previously developed models and predicted that E-cadherin
expression levels and b-catenin nuclear levels are uncoupled.
Contrasting results were observed for the mesoderm marker
Brachyury, whose expression has been shown to be regulated by
the Wnt pathway via TCF/LEF binding sites within the promoter
region [40]. Brachury mRNA was not detected in wtD3 or
Ecad-/- ES cell lines by RT-PCR or qPCR but was detected upon
treatment of the cells with BIO. However, the microarray analysis
showed a statistically significant 4.3-fold increase in Brachyury
transcripts in Ecad-/- ES cells compared to wtD3 ES cells
(q=0.04). These contrasting results might be explained by the
different sensitivity of the two methods, with the microarray
analysis able to detect differences even in very low transcriptionally
active genes. This is corroborated by our qPCR analysis of Fgf5
and Eomes, where levels were found to be an order of magnitude
lower than detected in the microarray, although the trends were
similar. The low Brachyury transcript expression in our study is in
contrast with Kemler and colleagues’ initial characterisation of
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but not wtD3 ES cells [2]. However, this discrepancy is likely to be
a result of different culture conditions used in these two studies.
Our analysis was performed in ES cells cultured in ES cell
screened FBS in the absence of a fibroblast feeder layer, which
results in low Wnt activity in wt mES cells [13]. In contrast,
Kemler and colleagues cultured their ES cells in buffalo rat liver
(BRL)-conditioned medium which may contain higher levels of
Wnt proteins or other exogenous factors which could promote
brachyury expression in Ecad-/- ES cells.
In the comparison of gene expression profiles of wtD3 and
Ecad-/- ES cells cultured under standard LIF conditions, we
obtained more than 2200 genes exhibiting statistically significant
difference in transcript expression and these were involved in
various fundamental biological processes. Microarray data can be
analysed according to the predominance of gene ontology terms.
In our analysis, we considered GO terms of the Molecular
Function (MF) and Biological Process (BP) branches up to level 5.
The extent of GO terms associated with Ecad-/- ES cell transcript
alterations is surprising and demonstrates that E-cadherin protein
plays a major function in maintaining the transcriptional
phenotype of mouse ES cells. Indeed, E-cadherin functions as
both a positive- and negative-effector of transcripts associated with
a breadth of cellular processes. Whilst further experimental
analysis of the biological relevance of these transcript alterations
is desirable, it does suggest that E-cadherin plays an important role
in regulating numerous cellular processes that, as yet, have not
been attributed to this protein. Since microarray analysis is a
subjective process (for example, we have determined that fold-
changes #2.50 and $2.50 are significant and only GO terms with
at least 10 genes were included) it is likely that E-cadherin
regulates many other cellular processes that do not meet our
assessment criteria. We discuss transcript alterations of some genes
associated within specific gene ontology terms in Text S1.
The most abundant term identified in the KEGG pathway
analysis (Figure S2) was ‘‘pathways in cancer’’, with 72 gene
transcript alterations. Genes represented in this category are also
associated with melanoma (mmu05218), prostate cancer
(mmu05215), colorectal cancer (mmu05210), basal cell carcinoma
(mmu05217), renal cell carcinoma (mmu05211) and glioma
(mmu05214). When viewed in the context of metastatic transfor-
mation of epithelial cancer cells, with the proviso that the effects of
E-cadherin in mES cells are mirrored in human epithelial cells,
these observations may explain why loss of E-cadherin in epithelial
tumours is associated with a more aggressive phenotype. Loss of E-
cadherin is a commoncharacteristic of aggressive epithelial tumours
and is frequently associated with an EMT event, leading to
upregulation of various MMPs and acquisition of a more motile
phenotype, which increases the metastatic property of the cells [1].
However, our study suggests that E-cadherin might exert a much
wider impact on the gene expression profile of cancer cells, affecting
general biological processes of the cells as well as increased motility.
In this study we have observed modified transcript levels of anti-
apoptoticgenes,alterationsinthe cellularmetabolism and cell cycle.
Such modifications, together with the altered response to growth
factors present in the environment, might represent a significant
survival and proliferative advantage for tumour cells [43].
Conclusion
Our data show that loss of E-cadherin has effects not only
confined to cellular adhesion but also on the general biology of ES
cells. We have demonstrated that Ecad-/- ES cells exhibit gene
expression profiles more similar to EpiS cells and FABS cells than
to wt ES cells. However, they clearly present a unique gene
expression profile. We have also shown that expression of E-
cadherin influences the levels of total b-catenin protein as
demonstrated by the decreased b-catenin levels in E-cadherin
depleted cells (Ecad-/- and EcadRNAi). b-catenin protein in
Ecad-/- ES cells is distributed equally between the cytoplasm and
the nucleus. However, the nuclear fraction of b-catenin does not
exhibit significant transactivity, suggesting that loss of E-cadherin
alone is insufficient to induce b-catenin/TCF transactivation.
Overall, these results suggest a much wider role for E-cadherin in
regulating cellular homeostasis than is currently presumed and,
following abrogation of this control, significant alterations in
cellular phenotype occur that may then reflect the critical role of
this protein in embryogenesis and the more aggressive phenotype
of metastatic tumour cells.
Supporting Information
Figure S1 Principal component analysis map of the
microarray data. The graph shows that component 1 clearly
distinguished between the data set of wtD3 samples (red) from
those of the two Ecad-/- ES cell samples (with and without LIF,
blue and green respectively). By contrast, no component was able
to distinguish between Ecad-/- ES cells grown in the presence or
absence of LIF.
(TIF)
Figure S2 KEGG pathway analysis. Pie chart showing the
most represented KEGG pathway terms in the comparison
between wtD3 and Ecad-/- ES cell transcripts. The most
represented term is ‘‘pathways in cancers’’ while 6 terms are
related to various metabolic processes, confirming the observation
in the GO analysis. Four terms are related to cell adhesion,
particularly focal adhesion, tight and gap junctions. Wnt pathway
is the second most abundant signalling cascade after MAPK,
followed by Hedgehog.
(TIF)
Figure S3 Analysis of proliferation and cell cycle in
wtD3 and Ecad-/- ES cells. Proliferation of wtD3 and Ecad-/-
ES cells was assessed over 5 days and cumulative viable cell
numbers measured over this period (A). Cell cycle analysis of wtD3
and Ecad-/- ES cells cultured in the presence of LIF (B).
(TIF)
Figure S4 Network of transcripts associated with the
Wnt signalling pathway. Transcripts exhibiting altered
expression in Ecad-/- ES cells are highlighted: upregulated
transcripts are shown in green and downregulated transcripts
shown in red (with fold-change indicated by the number).
Reproduced with kind permission from WikiPathways (http://
creativecommons.org/licenses/by/3.0/).
(TIF)
Figure S5 qPCR snd RT-PCR analysis of EpiSC-associ-
ated transcripts in Ecad-/- ES cells compared to wtD3
ES cells. qPCR analysis of FGF5, Eomes, Gbx2, Blimp1, Lefty2,
Stella/Dppa3, SSEA-1 and Nodal in Ecad-/- ES cells compared
to wtD3 ES cells (A). This analysis confirms the results of the
microarray data. B. RT-PCR analysis of Otx2, Pitx2, Nodal and
Acvr2b demonstrating similar expression of these transcripts in
Ecad-/- and wtD3 ES cells. (bt=b-tubulin, loading control).
(TIF)
Table S1 Primer sequences for RT-PCR analysis.
(DOC)
Table S2 Primer sequences for qPCR analysis.
(DOC)
Global Transcript Alterations in Ecad-/- ES Cells
PLoS ONE | www.plosone.org 12 July 2011 | Volume 6 | Issue 7 | e21463Table S3 Signalling pathways identified in the micro-
array analysis as exhibiting significant alterations in
Ecad-/- compared to wtD3 ES cells.
(DOC)
Table S4 20 most upregulated probes in wtD3 vs
Ecad-/- compared to wtES vs EpiSCs. (FC=fold-change)
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